DE3576495D1 - 5-(3,5-disubstituierte phenylazo)-2-hydroxyphenylessigsaeuren, deren salze und lactone, und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents

5-(3,5-disubstituierte phenylazo)-2-hydroxyphenylessigsaeuren, deren salze und lactone, und diese enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
DE3576495D1
DE3576495D1 DE8585905923T DE3576495T DE3576495D1 DE 3576495 D1 DE3576495 D1 DE 3576495D1 DE 8585905923 T DE8585905923 T DE 8585905923T DE 3576495 T DE3576495 T DE 3576495T DE 3576495 D1 DE3576495 D1 DE 3576495D1
Authority
DE
Germany
Prior art keywords
lactones
salts
pharmaceutical compositions
compositions containing
acetic acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585905923T
Other languages
English (en)
Inventor
Hubert Agback
Sigurd Nygren
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia AB filed Critical Pharmacia AB
Application granted granted Critical
Publication of DE3576495D1 publication Critical patent/DE3576495D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83—Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE8585905923T 1984-11-23 1985-11-13 5-(3,5-disubstituierte phenylazo)-2-hydroxyphenylessigsaeuren, deren salze und lactone, und diese enthaltende pharmazeutische zusammensetzungen. Expired - Fee Related DE3576495D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8405924A SE8405924L (sv) 1984-11-23 1984-11-23 Nya azoforeningar
PCT/SE1985/000453 WO1986003195A1 (en) 1984-11-23 1985-11-13 Novel azo compounds

Publications (1)

Publication Number Publication Date
DE3576495D1 true DE3576495D1 (de) 1990-04-19

Family

ID=20357885

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585905923T Expired - Fee Related DE3576495D1 (de) 1984-11-23 1985-11-13 5-(3,5-disubstituierte phenylazo)-2-hydroxyphenylessigsaeuren, deren salze und lactone, und diese enthaltende pharmazeutische zusammensetzungen.

Country Status (8)

Country Link
US (1) US4725676A (de)
EP (1) EP0203957B1 (de)
JP (1) JPS62500872A (de)
CN (1) CN1004352B (de)
CA (1) CA1256102A (de)
DE (1) DE3576495D1 (de)
SE (1) SE8405924L (de)
WO (1) WO1986003195A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709248D0 (en) * 1987-04-16 1987-05-20 Wyeth John & Brother Ltd Azo compounds
ATE448194T1 (de) 2000-08-29 2009-11-15 Biocon Ltd Verwendung einer pharmazeutischen zusammensetzung mit einem para-aminophenylessigsäurederivat für die behandlung von entzündlichen erkrankungen des magen-darmtrakts
US8048924B2 (en) * 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
CA2515440A1 (fr) * 2003-02-12 2004-09-02 L'oreal Utilisation d'un inhibiteur de 15-hydroxy prostaglandine deshydrogenase pour favoriser la pigmentation de la peau ou des phaneres
ATE554752T1 (de) 2004-02-06 2012-05-15 Pharmatel R & D Pty Ltd As Trustee For The Pharmatel R & D Trust Verwendung von aminosalicylaten beim reizdarmsyndrom mit durchfall als vorherrschendem symptom
US20080306029A1 (en) * 2004-05-28 2008-12-11 Salix Pharmaceuticals, Inc. Prevention, Treatment, and Amelioration of Radiation Induced Enteritis
WO2006014549A2 (en) * 2004-07-07 2006-02-09 Nobex Corporation Synthesis of azo bonded immunoregulatory compounds
US8921344B2 (en) * 2006-11-03 2014-12-30 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
US7452872B2 (en) 2005-08-24 2008-11-18 Salix Pharmaceuticals, Inc. Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives
CN103948609A (zh) * 2005-08-24 2014-07-30 萨利克斯药品公司 巴柳氮制剂及其生产和应用
US9452578B2 (en) 2013-07-26 2016-09-27 Corning Incorporated Fast firing method for high porosity ceramics
US9789116B2 (en) 2013-10-15 2017-10-17 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity
US10945998B2 (en) 2015-03-08 2021-03-16 Case Western Reserve University Inhibitors of short-chain dehydrogenase activity for treating fibrosis
JP2020502070A (ja) 2016-11-30 2020-01-23 ケース ウエスタン リザーブ ユニバーシティ １５−ｐｇｄｈ阻害剤とコルチコステロイドおよび／またはｔｎｆ阻害剤との組み合わせならびにその使用
JP2020514323A (ja) 2017-02-06 2020-05-21 ケース ウエスタン リザーブ ユニバーシティ 短鎖デヒドロゲナーゼ活性を調節する組成物と方法
WO2020106998A1 (en) 2018-11-21 2020-05-28 Case Western Reserve University Compositions and methods of modulating short-chain dehydrogenase activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE631326A (de) * 1962-04-23
US3302992A (en) * 1962-06-22 1967-02-07 Polyolefins dyed with gamma-resorcylic acid azo dyes
SE7905051L (sv) * 1979-06-11 1980-12-12 Pharmacia Ab Nya sulfonamider
SE8002322L (sv) * 1980-03-26 1981-09-27 Pharmacia Ab Medel for behandling av inflammatoriska tarmsjukdomar
DE3027013A1 (de) * 1980-07-17 1982-02-18 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Mittel zur behandlung von colitis ulcerosa, enteritis regionalis crohn (morbus crohn), chronischer unspezifischer colitis und divertikulitis sowie verwendung von salicylazobenzoesaeure, zur herstellung von derartigen mitteln
US4412992A (en) * 1980-07-21 1983-11-01 Biorex Laboratories Limited 2-Hydroxy-5-phenylazobenzoic acid derivatives and method of treating ulcerative colitis therewith
US4312806A (en) * 1981-03-02 1982-01-26 G. D. Searle & Co. Method and compounds for treating inflammatory bowel disease
US4374932A (en) * 1981-06-08 1983-02-22 G. D. Searle & Co. 5-ASA Drug delivery system
DE3408152A1 (de) * 1984-03-06 1985-09-12 Cassella Ag, 6000 Frankfurt Monoazofarbstoffe, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
WO1986003195A1 (en) 1986-06-05
SE8405924L (sv) 1986-05-24
CA1256102A (en) 1989-06-20
CN85109684A (zh) 1987-04-15
US4725676A (en) 1988-02-16
CN1004352B (zh) 1989-05-31
JPS62500872A (ja) 1987-04-09
EP0203957A1 (de) 1986-12-10
SE8405924D0 (sv) 1984-11-23
EP0203957B1 (de) 1990-03-14

Similar Documents

Publication Publication Date Title
DE3576495D1 (de) 5-(3,5-disubstituierte phenylazo)-2-hydroxyphenylessigsaeuren, deren salze und lactone, und diese enthaltende pharmazeutische zusammensetzungen.
DE69015842D1 (de) Nicotinsäurederivate und diese enthaltende pharmazeutische Zusammensetzungen.
DE3877406D1 (de) Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
IE820856L (en) Omega-cyano-1,omega-diphenyl-azaalkane derivatives.
NZ241253A (en) 2,8-dioxabicyclo(3.2.1)octane-4,5-dicarboxylic acid derivatives; their preparation, intermediates therefor and medicaments
IT1190824B (it) Composizione farmaceutica contenente 24,25-diidrossicolecalciferolo come ingrediente attivo
NZ231353A (en) Pharmaceutical compositions comprising 3,5-dihydroxy-7-(1-acyloxyhexahydronaphth-8-yl)-heptanoic acid and lactone derivatives
AU541725B2 (en) Substituted 1,2,5-oxadiazole-2-oxides as pharmaceutical activ cpds,their use and medicaments containing them
DE3583765D1 (de) Hydantoinderivate und diese enthaltende pharmazeutische zusammensetzungen.
DZ327A1 (fr) Imino diacides substitutes, leur préparation e composition pharmaceutiques les contenant.
FI883673A (fi) Farmaceutiska kompositioner.
IT7926662A0 (it) Composizione farmaceutica contenente 3,4-di-idro-3-osso-2-chinossaline.
ATE5188T1 (de) Phenylalkansaeure-derivate, deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE3578597D1 (de) 4-phenylphthalazin-derivate, deren herstellung und diese enthaltende pharmazeutische zusammenstellungen.
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
IT8121654A0 (it) Derivati tiazolidinici ad attivita' farmacologica, procedimento per la loro preparazione e composizioni farmaceutiche contenenti detti derivati.
DE3668458D1 (de) Antihelmintische macrocyclische lactone und ihre fermentative herstellung.
ATE50984T1 (de) 5-(3,5-disubstituierte phenylazo)-2hydroxyphenylessigs|uren,deren salze und lactone, und diese enthaltende pharmazeutische zusammensetzungen.
FI94087C (fi) Mikrobienvastainen koostumus, joka sisältää 2-(2-bromi-2-nitroetenyyli)furaania, ja sen käyttö
DE3684756D1 (de) Durch (omega-amino)-alkanolgruppen substituierte aromatische derivate mit antimikrobenwirkung und diese enthaltende zusammensetzungen.
DE3766418D1 (de) Substituierte benzimidazolylthiomethylbenzothiazol-derivate und deren salze, verfahren zu deren herstellung, deren medizinische anwendung und diese enthaltende zusammenstellungen.
DE3669713D1 (de) Alkylaminoamide und ihre salze, ihre herstellung, ihre verwendung als arzneimittel und diese verbindungen enthaltende zusammensetzungen.
NZ189211A (en) 1,4-cyclohexadiene carboxylic acid derivatives and pharmaceutical compositions
FR2600065B1 (fr) Nouveaux derives de l'acide 5-((2-benzofuranyl) carbonyl) thiophene acetique, leurs sels, leurs procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2470111B1 (fr) Derives de la decaprenylamine, leurs sels acides d'addition et composition pharmaceutique utilisant ces produits

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee